NR1H4 and metabolic dysfunction-associated steatohepatitis: Whole body and liver-specific FXR -/- mice develop steatosis and NASH; however, whole-body but not liver-specific FXR-/- mice are less prone to gain weight and to develop insulin resistance than the wild type animals [82,83,84].